Audio Journal of Oncology Podcast Mark A Dickson, ASCO 2026: Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with...
Clear-cell renal cell cancer: first molecular prognostic marker also brings scope for drug targeting
SAN FRANCISCO— A recently discovered molecular prognostic biomarker for clear-cell renal cell cancer has been validated and shown to indicate a four...